An International Journal of Otorhinolaryngology Clinics

Register      Login

VOLUME 13 , ISSUE 2 ( May-August, 2021 ) > List of Articles

CASE REPORT

Bilateral Facial Nerve Schwannoma: A Case Report and Review of the Literature

Kayvan Aghazadeh, Benyamin Rahmaty, Ali Kouhi, Sasan Dabiri, Saeed Sohrabpour, Maryam Mohammadzadeh, Neda Jafari

Keywords : Bilateral hemifacial spasm, Botulinum toxin, Facial nerve schwannoma, Hemifacial spasm

Citation Information : Aghazadeh K, Rahmaty B, Kouhi A, Dabiri S, Sohrabpour S, Mohammadzadeh M, Jafari N. Bilateral Facial Nerve Schwannoma: A Case Report and Review of the Literature. Int J Otorhinolaryngol Clin 2021; 13 (2):47-52.

DOI: 10.5005/jp-journals-10003-1374

License: CC BY-NC 4.0

Published Online: 20-11-2021

Copyright Statement:  Copyright © 2021; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Aim and objective: To show a case with bilateral hemifacial spasm and bilateral facial nerve schwannoma (FNS) and explain few differential diagnoses for the facial nerve schwannomas, clinical presentation, genetic association, and their CT and MRI characteristics. Background: Hemifacial spasm (HFS) is a hyperactive cranial neuropathy that causes paroxysmal facial muscle contraction. Bilateral hemifacial spasm (BHFS) is a very rare neurological syndrome whose diagnosis depends on excluding other facial dyskinesias. Facial nerve schwannoma (FNS) potentially affects any segment of the facial nerve (FN). Bilateral hemifacial spasm caused by bilateral FNS is a rare presentation also. Case description: The patient was a 39-year-old female with bilateral HFS and bilateral FNS. Grade II House-Brackmann Facial Nerve Grading System was observed on the right side of her face. Continuous facial tics were occurring during the examination on both sides of her face, particularly around the left eye. The patient was received bilateral injections of botulinum toxin A. The patient underwent a scheduled close follow-up regarding hearing, facial nerve function, signs, and symptoms. In 1-month, 3-month, 6-month, and a year follow-ups, her symptoms were improved. We performed another MRI following a year, and the sizes of the lesions were equal as the first MRI. The patient was received bilateral injections of botulinum toxin A every 6 months. We decided to follow her up every 6 months for injection and every year by imaging. Conclusion: Surgery is a good option to remove the FNS, but close follow-up and symptomatic treatment, sometimes, are the best approaches when there are no significant facial nerve palsy and hearing loss.


PDF Share
  1. O'Donoghue GM, Brackmann DE, House JW, et al. Neuromas of the facial nerve. Am J Otol 1989 Jan;10(1):49–54. PMID: 2719087.
  2. Symon L, Cheesman AD, Kawauchi M, et al. Neuromas of the facial nerve: a report of 12 cases. Br J Neurosurg 1993;7(1):13–22. DOI: 10.3109/02688699308995051.
  3. Balle VH, Greisen O. Neurilemmomas of the facial nerve presenting as parotid tumors. Ann Otol Rhinol Laryngol 1984;93(1):70–72. DOI: 10.1177/000348948409300116.
  4. Wiggins RH, Harnsberger HR, Salzman KL, et al. The many faces of facial nerve schwannoma. AJNR Am J Neuroradiol 2006 Mar;27(3):694-9. PMID: 16552018; PMCID: PMC7976970.
  5. Mundada P, Purohit BS, Kumar TS, et al. Imaging of facial nerve schwannomas: diagnostic pearls and potential pitfalls. Diagn Interv Radiol 2016;22(1):40–46. DOI: 10.5152/dir.2015.15060.
  6. Dort JC, Fisch U. Facial nerve schwannomas. Skull Base 1991;1(01): 51–56. DOI: 10.1055/s-2008-1056979.
  7. Carlson ML, Deep NL, Patel NS, et al. Facial nerve schwannomas: review of 80 cases over 25 years at Mayo Clinic. Mayo Clin Proc 2016;91(11):1563–1576. DOI: 10.1016/j.mayocp.2016.07.007.
  8. Flint P, Haughey B, Lund V, et al. Otolaryngology—head and neck surgery. 6th ed. 2015.
  9. Shimizu K, Iwai H, Ikeda K, et al. Intraparotid facial nerve schwannoma: a report of five cases and an analysis of MR imaging results. AJNR Am J Neuroradiol 2005 Jun-Jul;26(6):1328-30. PMID: 15956491; PMCID: PMC8149055.
  10. Singh S. Botulinum toxin in hemifacial spasm: revisited. Indian J Plastic Surg 2013;46(1):159–160. DOI: 10.4103/0970-0358.113746.
  11. Fenton JE, Morrin MM, Smail M, et al. Bilateral facial nerve schwannomas. Eur Arch Oto-Rhino-Laryngol 1999;256(3):133–135. DOI: 10.1007/s004050050125.
  12. Touska P, Juliano AFY. Temporal bone tumors. Neuroimaging Clin N Am 2019;29(1):145–172. DOI: 10.1016/j.nic.2018.09.007.
  13. Brackmann DE, Bartels LJ. Rare tumors of the cerebellopontine angle. Otolaryngol Head Neck Surg 1980;88(5):555–559. DOI: 10.1177/019459988008800508.
  14. Kim M, Rowed DW, Cheung G, et al. Cavernous malformation presenting as an extra-axial cerebellopontine angle mass: case report. Neurosurgery 1997;40(1):187–190. DOI: 10.1097/00006123-199701000-00041.
  15. Soldati D, Mudry A. Knowledge about cholesteatoma, from the first description to the modern histopathology. Otol Neurotol 2001;22(6):723–730. DOI: 10.1097/00129492-200111000-00003.
  16. Fedok FG, Bellissimo JB, Wiegand DA. Bilateral congenital aural cholesteatoma. Otolaryngol Head Neck Surg 1990;103(6):1028–1030. DOI: 10.1177/019459989010300624.
  17. Axon PR, Fergie N, Saeed SR, et al. Petrosal cholesteatoma: management considerations for minimizing morbidity. Am J Otol 1999 Jul;20(4):505-10. PMID: 10431894.
  18. Roger P. Simon MJA, Greenberg DA. Clinical neurology. 10th ed. The McGraw-Hill Companies; 2018.
  19. Lefaucheur JP, Ben Daamer N, Sangla S, et al. Diagnosis of primary hemifacial spasm. Neurochirurgie 2018;64(2):82–86. DOI: 10.1016/j.neuchi.2017.12.003.
  20. Xiao L, Pan L, Li B, et al. Botulinum toxin therapy of hemifacial spasm: bilateral injections can reduce facial asymmetry. J Neurol 2018;265(9):2097–2105. DOI: 10.1007/s00415-018-8960-2.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.